BREAST DUCTAL CARCINOMA IN SITU
Clinical trials for BREAST DUCTAL CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new BREAST DUCTAL CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for BREAST DUCTAL CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a vaccine stop breast cancer before it starts?
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a vaccine called H2NVAC in people with a very early form of breast cancer called DCIS that has the HER2 protein. The vaccine is given before surgery to see if it can train the immune system to fight the cancer and possibly prevent it from coming back. The main go…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: ⭐️ VACCINE ⭐️
Last updated May 07, 2026 18:40 UTC
-
Could eating less boost Radiation's power against breast cancer?
Disease control Recruiting nowThis study looks at whether cutting calories while getting focused radiation (SABR) before surgery can shrink breast tumors more than radiation alone. About 80 adults with early-stage breast cancer will be randomly assigned to one of two groups. The goal is to see if the diet hel…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Glowing needle could spot tiny breast tumors in real time
Diagnosis Recruiting nowThis study tests a new glowing needle that helps doctors find and sample very small abnormal areas inside breast ducts during surgery. The needle has a special coating that lights up, making it easier to see and remove the right tissue. About 300 women having breast duct surgery …
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: The Fourth Affiliated Hospital of China Medical University • Aim: Diagnosis
Last updated May 13, 2026 15:59 UTC
-
Could a lower tamoxifen dose prevent breast cancer in High-Risk women?
Prevention Recruiting nowThis study is for premenopausal women at higher-than-average risk for breast cancer. It tests whether a low dose of tamoxifen, adjusted based on each woman's response, can safely reduce breast density—a key risk factor for breast cancer. About 200 women will take part, and the go…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 26, 2026 10:49 UTC
-
New study tests tamoxifen and Omega-3 combo to slash breast cancer risk in overweight women
Prevention Recruiting nowThis study looks at whether taking low-dose tamoxifen, alone or with high-dose omega-3 fatty acids, can lower breast cancer risk in overweight or obese postmenopausal women who are already at higher risk. About 66 women will take part. The goal is to see if adding omega-3s improv…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 22, 2026 14:05 UTC
-
New hope for High-Risk women: can acolbifene outdo tamoxifen in breast cancer prevention?
Prevention Recruiting nowThis study tests two drugs, acolbifene and low-dose tamoxifen, to see which works better at preventing breast cancer in premenopausal women at high risk. Both drugs block estrogen from fueling breast cell growth. About 80 women will take one of the drugs for six months, and resea…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 14, 2026 12:05 UTC
-
CBD extract tested to ease joint pain in breast cancer survivors
Symptom relief Recruiting nowThis study tests a high-CBD plant extract (BRC-001) to see if it can reduce joint pain and stiffness in women with breast cancer who take aromatase inhibitors (AIs). AIs lower estrogen to prevent cancer return but often cause arthritis-like side effects, leading some women to sto…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC
-
Pandemic's hidden cost: breast cancer patients face financial strain
Knowledge-focused Recruiting nowThis study looks at how the COVID-19 pandemic impacted the financial burden on breast cancer patients having surgery. Researchers will survey 600 patients about out-of-pocket costs, lost wages, and economic strain. The goal is to understand the financial challenges these patients…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 10:50 UTC
-
New study aims to close gaps in breast cancer care
Knowledge-focused Recruiting nowThis study is testing a patient navigation program for 126 newly diagnosed breast cancer patients. The program helps patients understand their care options, connect with support services, and overcome barriers to treatment. The goal is to see if this approach can improve health e…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Knowledge-focused
Last updated May 26, 2026 10:48 UTC
-
Free genetic testing could unlock hidden cancer risks for thousands
Knowledge-focused Recruiting nowThis study offers free genetic testing to the general public to find people with inherited cancer syndromes like hereditary breast and ovarian cancer or Lynch syndrome. Researchers want to see if broad testing is better than only testing those with a family history. Up to 27,500 …
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated May 26, 2026 10:46 UTC